Cardiac hypertrophy and hypertension

被引：11

作者：

Agabiti-Rosei, E ^{[1
]}

Muiesan, ML ^{[1
]}

机构：

[1] Univ Brescia, Cattedra Semeiot & Metodol Med, UOP Sci Med, I-25100 Brescia, Italy

来源：

CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION | 1998年 / 7卷 / 02期

关键词：

D O I：

10.1097/00041552-199803000-00011

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

In the general population and in patients with essential hypertension the presence of left ventricular hypertrophy is a powerful predictor of cardiovascular events, independent of blood pressure and other cardiovascular risk factors. The prevalence of left ventricular hypertrophy increases with age and with the severity of renal impairment. Left ventricular hypertrophy is also a sensitive indicator of vascular structural changes in both large and small arteries. The possibility of reversing left ventricular hypertrophy therefore represents a major therapeutic goal for the treatment of hypertensive patients. Several studies examining the characteristics of left ventricular hypertrophy in the elderly, the interrelations between cardiac and vascular hypertrophy, the possibility of reversing left ventricular hypertrophy and its consequent prognostic value will be reported and commented on in the present review. (C) 1998 Rapid Science Ltd.

引用

页码：211 / 216

页数：6

共 46 条

[1] ACE inhibitor ramipril is more effective than the beta-blocker atenolol in reducing left ventricular mass in hypertension. Results of the RACE (ramipril cardioprotective evaluation) study [J].

AgabitiRosei, E ;

Ambrosioni, E ;

DalPalu, C ;

Muiesan, ML ;

Zanchetti, A .

JOURNAL OF HYPERTENSION, 1995, 13 (11) :1325-1334

[2]

Andren B, 1996, EUR HEART J, V17, P1800

[3] LEFT-VENTRICULAR HYPERTROPHY IS MORE PREVALENT IN PATIENTS WITH SYSTEMIC HYPERTENSION WITH EXTRACRANIAL CAROTID ARTERIAL-DISEASE THAN IN PATIENTS WITH SYSTEMIC HYPERTENSION WITHOUT EXTRACRANIAL CAROTID ARTERIAL-DISEASE [J].

ARONOW, WS ;

KRONZON, I ;

SCHOENFELD, MR .

AMERICAN JOURNAL OF CARDIOLOGY, 1995, 76 (03) :192-193

[4] GEOMETRIC CHANGES ALLOW NORMAL EJECTION FRACTION DESPITE DEPRESSED MYOCARDIAL SHORTENING IN HYPERTENSIVE LEFT-VENTRICULAR HYPERTROPHY [J].

AURIGEMMA, GP ;

SILVER, KH ;

PRIEST, MA ;

GAASCH, WH .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (01) :195-202

[5] VALUE OF ECHOCARDIOGRAPHIC MEASUREMENT OF LEFT-VENTRICULAR MASS IN PREDICTING CARDIOVASCULAR MORBID EVENTS IN HYPERTENSIVE MEN [J].

CASALE, PN ;

DEVEREUX, RB ;

MILNER, M ;

ZULLO, G ;

HARSHFIELD, GA ;

PICKERING, TG ;

LARAGH, JH .

ANNALS OF INTERNAL MEDICINE, 1986, 105 (02) :173-178

[6]

CRUICKSHANK JM, 1992, J HUM HYPERTENS, V6, P85

[7] Left ventricular concentric remodelling and carotid structural changes in essential hypertension [J].

Cuspidi, C ;

Lonati, L ;

Sampieri, L ;

Pelizzoli, S ;

Pontiggia, G ;

Leonetti, G ;

Zanchetti, A .

JOURNAL OF HYPERTENSION, 1996, 14 (12) :1441-1446

[8]

Cuspidi C, 1995, J HYPERTENS, V13, P1707

[9] REVERSAL OF LEFT-VENTRICULAR HYPERTROPHY IN HYPERTENSIVE PATIENTS - A METAANALYSIS OF 109 TREATMENT STUDIES [J].

DAHLOF, B ;

PENNERT, K ;

HANSSON, L .

AMERICAN JOURNAL OF HYPERTENSION, 1992, 5 (02) :95-110

[10] IMPACT OF AGE ON ECHOCARDIOGRAPHIC LEFT-VENTRICULAR MASS IN A HEALTHY POPULATION (THE FRAMINGHAM-STUDY) [J].

DANNENBERG, AL ;

LEVY, D ;

GARRISON, RJ .

AMERICAN JOURNAL OF CARDIOLOGY, 1989, 64 (16) :1066-1068

← 1 2 3 4 5 →